Publication number: 20070021611
Abstract: The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1: and the pharmaceutically acceptable salts, solvates and esters thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non-limiting example(s) include, psoriasis), autoimmune diseases (non-limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non-limiting example(s) include, allograft rejection, xenograft rejection), infectious diseases (e.
Type:
Application
Filed:
February 14, 2006
Publication date:
January 25, 2007
Inventors:
Brian McGuinness, Stuart Rosenblum, Joseph Kozlowski, Gopinadhan Anilkumar, Seong Kim, Neng-Yang Shih, Chung-Her Jenh, Paul Zavodny, Douglas Hobbs, Guizhen Dong, Yuefei Shao, Lisa Zawacki, Cangming Yang, Carolyn Carroll